Protecting the stomach from steroid side effects in lupus
Treatments studied
Part of Digestive system clinical trials.
This study tests a medicine called teprenone to see if it can protect the stomach from damage caused by steroids (prednisone), which are often used to treat lupus. If you have lupus and are taking steroids, this study may help reduce stomach problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with systemic lupus erythematosus (SLE), a condition where your immune system attacks your body.
- You are currently taking a moderate to high dose of steroids (like prednisone) at 30-60 mg every day.
- You are willing to participate and sign a consent form.
- You do not have other stomach issues like active ulcers, bleeding, or history of stomach surgery.
- You do not have severe heart problems or certain lab test abnormalities (like high liver enzymes or low kidney function).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether people with proliferative lupus nephritis can use less steroid medicine while still controlling kidney inflammation. It may help reduce steroid side effects, while testing a carefully monitored treatment plan.
This trial tests whether a lower starting dose of steroids can control kidney inflammation in children with lupus nephritis. It aims to reduce side effects while still treating the disease effectively.
This study measures blood levels of high-dose steroid medicines (prednisolone or related steroids) to understand how the body processes them in different real-life situations. It may help improve how steroids are dosed and monitored for people needing short-term or longer-term anti-inflammatory treatment.
This study tests a nurse-led program to help prevent complications from taking corticosteroids (steroid medicines) for a long time. If you’ve recently started high-dose steroid treatment, this could offer structured support to reduce risks.
This trial tests whether adding standard oral steroid tablets to mycophenolate helps lupus nephritis (inflammation of the kidneys) more than using obinutuzumab plus mycophenolate, without extra oral steroids. It may help find a treatment plan that controls active kidney disease while changing how much steroid is used.
This trial tests a new treatment for people with active lupus who haven't responded well to steroids and at least two other immune-suppressing drugs, including a biologic. It aims to find a better option for controlling lupus symptoms.
Hear when a new Gastrointestinal and Digestive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.